Clinical Trials Browser

OTHER × Neoplasm Metastasis × vandetanib × Clear all

NCT01582191 2025-10-27

Vandetanib and Everolimus in Treating Patients With Advanced or Metastatic Cancer

Phase 1 Completed

Neoplasm Metastasis, Neoplasms, Recurrence

NCT02142036 2019-03-13

MetAction

Phase 2 Completed

Neoplasm Metastasis